Table 1 Characteristics of all included studies
Author | Year | Country | Study design | N | Source of sample | Outcome | NOS score |
|---|---|---|---|---|---|---|---|
Duan [9] | 2023 | China | Retrospective | 121 | Blood | 1,5,6 | 8 |
Zhang [10] | 2023 | China | Prospective | 107 | Blood | 1 | 8 |
Bilgin [11] | 2023 | Turkey | Retrospective | 166 | Blood | 1,4 | 6 |
Chen [12] | 2022 | China | Prospective | 152 | Blood | 2,5 | 6 |
Wu [13] | 2022 | China | Retrospective | 74 | Blood | 5 | 8 |
Chen’ [14] | 2022 | China | Retrospective | 104 | Blood | 1,4,5,6, | 7 |
Huang [15] | 2022 | China | Prospective | 46 | Not mention | 1,4,5,7 | 7 |
Liang [16] | 2022 | China | Retrospective | 146 | Blood | 4 | 6 |
Hu [17] | 2021 | China | Prospective | 35 | Blood | 5,3,6,7 | 6 |
Yan [18] | 2021 | China | Retrospective | 221 | Blood | 1 | 8 |
Peng [19] | 2020 | China | Prospective | 90 | Blood | 5,2,3 | 6 |
Leijte [20] | 2020 | France | Retrospective | 141 | Blood | 1 | 8 |
Meng [21] | 2019 | China | Retrospective | 69 | Not mention | 5, | 6 |
Grande [22] | 2019 | Spain | Prospective | 22 | Blood | 1,5 | 7 |
Gai [23] | 2018 | China | Retrospective | 132 | Blood | 1,2,3,5,7 | 9 |
Zhang [24] | 2018 | China | Prospective | 200 | Blood | 5 | 7 |
Liu [25] | 2018 | China | Retrospective | 98 | Blood | 2,5 | 5 |
Lu [26] | 2018 | China | Prospective | 26 | Blood | 4,5 | 7 |
Yunus [27] | 2018 | USA | Retrospective | 188 | Not mention | 1,5,6 | 7 |
Lang [28] | 2017 | China | Prospective | 50 | Blood | 2,5,6 | 6 |
Li [29] | 2017 | China | Prospective | 82 | Abdominal puncture | 1,5 | 7 |
Liu [30] | 2017 | China | Prospective | 120 | Blood | 4,5, | 6 |
Gao [31] | 2017 | China | Retrospective | 92 | Blood | 2,5,8 | 7 |
Liu’ [32] | 2017 | China | Retrospective | 147 | Blood | 4,5 | 7 |
Tunjungputri [33] | 2017 | Netherlands | Prospective | 32 | Blood | 5 | 7 |
Zhou [34] | 2016 | China | Prospective | 112 | Blood | 5 | 6 |
Li [35] | 2016 | China | Retrospective | 298 | Blood | 1,5 | 7 |
Surbatovic [36] | 2015 | Serbia | Prospective | 145 | Blood | 1 | 6 |
Chen [37] | 2015 | China | Retrospective | 136 | Blood | 5 | 7 |
Zhao [38] | 2015 | China | Retrospective | 292 | Blood | 4,5 | 6 |
Guo [39] | 2015 | China | Retrospective | 101 | Blood | 4 | 7 |
Aydemir [40] | 2015 | Turkey | Retrospective | 192 | Blood | 1 | 6 |
Liu [41] | 2014 | China | Retrospective | 126 | Blood | 2,5 | 6 |
Gao [42] | 2014 | China | Retrospective | 73 | Body fluids | 5 | 7 |
Su [43] | 2014 | China | Prospective | 26 | Body fluids | 5 | 6 |
Chen [44] | 2014 | China | Retrospective | 132 | Blood | 5 | 6 |
Björnsson [45] | 2014 | Sweden | Prospective | 22 | Not mention | 1 | 8 |
Nakajima [46] | 2014 | Japan | Prospective | 14 | Blood | 1,5 | 6 |
Angeletti [47] | 2013 | Italy | Prospective | 152 | Blood | 5 | 7 |
Labelle [48] | 2012 | USA | Retrospective | 436 | Blood | 1,5 | 8 |
Abe [6] | 2010 | Japan | Retrospective | 238 | Blood | 1,2,3,5,8 | 7 |
Cheng [49] | 2007 | China | Prospective | 317 | Body fluids | 1 | 7 |
Feezor [50] | 2003 | USA | Prospective | 52 | Not mention | 5 | 7 |
Blairon [51] | 2003 | Belgium | Prospective | 35 | Blood | 5 | 6 |
Holub [52] | 2003 | Czech Republic | Prospective | 20 | Body fluids | 1,2,3,5 | 7 |